SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma.

SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma.

Item
http://www.wikidata.org/entity/Q43139046
SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.Interstitial guidance of cancer invasion.Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis.Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysisMaitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.SPARC silencing inhibits the growth of acute myeloid leukemia transformed from myelodysplastic syndrome via induction of cell cycle arrest and apoptosis.High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer.SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer.Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer.Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction.Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition.Clinical significance of SPARC gene expression in patients with gastric cancer.SPARC inhibits breast cancer bone metastasis and may be a clinical therapeutic target.In phyllodes tumors of the breast expression of SPARC (osteonectin/BM40) mRNA by in situ hybridization correlates with protein expression by immunohistochemistry and is associated with tumor progression.Ductal carcinoma in situ on stereotactic biopsy of suspicious breast microcalcifications: Expression of SPARC (Secreted Protein, Acidic and Rich in Cysteine) can predict postoperative invasion.Clinical significance of secreted protein, acidic and cysteine-rich gene expression in patients with stage II/III gastric cancer following curative resection and adjuvant chemotherapy with S-1.
P2860

SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma.

Item
http://www.wikidata.org/entity/Q43139046
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
SPARC (osteonectin) in breast ...... of invasive ductal carcinoma.
@en
type
label
SPARC (osteonectin) in breast ...... of invasive ductal carcinoma.
@en
prefLabel
SPARC (osteonectin) in breast ...... of invasive ductal carcinoma.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
SPARC (osteonectin) in breast ...... of invasive ductal carcinoma.
@en
P2093
P304
P31
P356
10.1111/J.1524-4741.2009.00899.X
P433
P478
P50
P577
P698